Cargando…

Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers

BACKGROUND: In the search for new therapies novel drugs and medications are being discovered, developed and tested in laboratories. Highly diluted substances are intended to enhance immune system responses resulting in reduced frequency of various diseases, and often present no risk of serious side-...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Carolina C, Abud, Ana Paula R, de Oliveira, Simone M, de SF Guimarães, Fernando, de Andrade, Lucas F, Di Bernardi, Raffaello P, de O Coletto, Ediely L, Kuczera, Diogo, Da Lozzo, Eneida J, Gonçalves, Jenifer P, da S Trindade, Edvaldo, de F Buchi, Dorly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222609/
https://www.ncbi.nlm.nih.gov/pubmed/22029602
http://dx.doi.org/10.1186/1472-6882-11-101
_version_ 1782217204159217664
author de Oliveira, Carolina C
Abud, Ana Paula R
de Oliveira, Simone M
de SF Guimarães, Fernando
de Andrade, Lucas F
Di Bernardi, Raffaello P
de O Coletto, Ediely L
Kuczera, Diogo
Da Lozzo, Eneida J
Gonçalves, Jenifer P
da S Trindade, Edvaldo
de F Buchi, Dorly
author_facet de Oliveira, Carolina C
Abud, Ana Paula R
de Oliveira, Simone M
de SF Guimarães, Fernando
de Andrade, Lucas F
Di Bernardi, Raffaello P
de O Coletto, Ediely L
Kuczera, Diogo
Da Lozzo, Eneida J
Gonçalves, Jenifer P
da S Trindade, Edvaldo
de F Buchi, Dorly
author_sort de Oliveira, Carolina C
collection PubMed
description BACKGROUND: In the search for new therapies novel drugs and medications are being discovered, developed and tested in laboratories. Highly diluted substances are intended to enhance immune system responses resulting in reduced frequency of various diseases, and often present no risk of serious side-effects due to its low toxicity. Over the past years our research group has been investigating the action of highly diluted substances and tinctures on cells from the immune system. METHODS: We have developed and tested several highly diluted tinctures and here we describe the biological activity of M1, M2, and M8 both in vitro in immune cells from mice and human, and in vivo in mice. Cytotoxicity, cytokines released and NF-κB activation were determined after in vitro treatment. Cell viability, oxidative response, lipid peroxidation, bone marrow and lymph node cells immunophenotyping were accessed after mice in vivo treatment. RESULTS: None of the highly diluted tinctures tested were cytotoxic to macrophages or K562. Lipopolysaccharide (LPS)-stimulated macrophages treated with all highly diluted tinctures decreased tumour necrosis factor alpha (TNF-α) release and M1, and M8 decreased IFN-γ production. M1 has decreased NF-κB activity on TNF-α stimulated reporter cell line. In vivo treatment lead to a decrease in reactive oxygen species (ROS), nitric oxide (NO) production was increased by M1, and M8, and lipid peroxidation was induced by M1, and M2. All compounds enhanced the innate immunity, but M1 also augmented acquired immunity and M2 diminished B lymphocytes, responsible to acquired immunity. CONCLUSIONS: Based on the results presented here, these highly diluted tinctures were shown to modulate immune responses. Even though further investigation is needed there is an indication that these highly diluted tinctures could be used as therapeutic interventions in disorders where the immune system is compromised.
format Online
Article
Text
id pubmed-3222609
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32226092011-11-23 Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers de Oliveira, Carolina C Abud, Ana Paula R de Oliveira, Simone M de SF Guimarães, Fernando de Andrade, Lucas F Di Bernardi, Raffaello P de O Coletto, Ediely L Kuczera, Diogo Da Lozzo, Eneida J Gonçalves, Jenifer P da S Trindade, Edvaldo de F Buchi, Dorly BMC Complement Altern Med Research Article BACKGROUND: In the search for new therapies novel drugs and medications are being discovered, developed and tested in laboratories. Highly diluted substances are intended to enhance immune system responses resulting in reduced frequency of various diseases, and often present no risk of serious side-effects due to its low toxicity. Over the past years our research group has been investigating the action of highly diluted substances and tinctures on cells from the immune system. METHODS: We have developed and tested several highly diluted tinctures and here we describe the biological activity of M1, M2, and M8 both in vitro in immune cells from mice and human, and in vivo in mice. Cytotoxicity, cytokines released and NF-κB activation were determined after in vitro treatment. Cell viability, oxidative response, lipid peroxidation, bone marrow and lymph node cells immunophenotyping were accessed after mice in vivo treatment. RESULTS: None of the highly diluted tinctures tested were cytotoxic to macrophages or K562. Lipopolysaccharide (LPS)-stimulated macrophages treated with all highly diluted tinctures decreased tumour necrosis factor alpha (TNF-α) release and M1, and M8 decreased IFN-γ production. M1 has decreased NF-κB activity on TNF-α stimulated reporter cell line. In vivo treatment lead to a decrease in reactive oxygen species (ROS), nitric oxide (NO) production was increased by M1, and M8, and lipid peroxidation was induced by M1, and M2. All compounds enhanced the innate immunity, but M1 also augmented acquired immunity and M2 diminished B lymphocytes, responsible to acquired immunity. CONCLUSIONS: Based on the results presented here, these highly diluted tinctures were shown to modulate immune responses. Even though further investigation is needed there is an indication that these highly diluted tinctures could be used as therapeutic interventions in disorders where the immune system is compromised. BioMed Central 2011-10-26 /pmc/articles/PMC3222609/ /pubmed/22029602 http://dx.doi.org/10.1186/1472-6882-11-101 Text en Copyright ©2011 de Oliveira et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
de Oliveira, Carolina C
Abud, Ana Paula R
de Oliveira, Simone M
de SF Guimarães, Fernando
de Andrade, Lucas F
Di Bernardi, Raffaello P
de O Coletto, Ediely L
Kuczera, Diogo
Da Lozzo, Eneida J
Gonçalves, Jenifer P
da S Trindade, Edvaldo
de F Buchi, Dorly
Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title_full Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title_fullStr Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title_full_unstemmed Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title_short Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
title_sort developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222609/
https://www.ncbi.nlm.nih.gov/pubmed/22029602
http://dx.doi.org/10.1186/1472-6882-11-101
work_keys_str_mv AT deoliveiracarolinac developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT abudanapaular developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT deoliveirasimonem developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT desfguimaraesfernando developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT deandradelucasf developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT dibernardiraffaellop developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT deocolettoedielyl developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT kuczeradiogo developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT dalozzoeneidaj developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT goncalvesjeniferp developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT dastrindadeedvaldo developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers
AT defbuchidorly developmentsondrugdiscoveryandonnewtherapeuticshighlydilutedtincturesactasbiologicalresponsemodifiers